Vanguard reports 0 shares of Silgan after realignment
Silgan Holdings Inc: The Vanguard Group filed an amendment to its Schedule 13G/A reporting a disaggregated position after an internal realignment.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Silgan Holdings Inc: The Vanguard Group filed an amendment to its Schedule 13G/A reporting a disaggregated position after an internal realignment. The filing states that, following the realignment, certain Vanguard subsidiaries will report separately and The Vanguard Group reports 0 shares beneficially owned of Silgan common stock.
The filing explains this change relies on SEC Release No. 34-39538 (January 12, 1998) and that the subsidiaries pursue the same investment strategies; signature dated 03/27/2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does The Vanguard Group report for SLGN in this Schedule 13G/A?
Why did Vanguard change how it reports ownership for SLGN?
Does this filing indicate Vanguard subsidiaries still manage similar strategies for SLGN?
Who signed the Schedule 13G/A amendment for SLGN?
Is any other person reported as owning more than 5% of SLGN in this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.